CYT

Cyteir Therapeutics, Inc. Common Stock
CYT

Overview Fund Activity
Delisted

CYT was delisted on the 15th of March, 2024.

Back to rankings

45 hedge funds and large institutions have $56.8M invested in Cyteir Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
-7
Holders Change %
-13.46%
% of All Funds
0.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
8
Reduced
15
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BBA
1
Baker Bros. Advisors
New York
$7.9M
2
NM
2
Newtyn Management
New York
$1.81M
3
LCM
3
Laurion Capital Management
New York
$1.08M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$1.04M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.83M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$0
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$11.6M
4
BlackRock
4
BlackRock
New York
$601K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$231K
Name Holding Trade Value Shares
Change 		Shares
Change %
Allspring Global Investments
51
Allspring Global Investments
North Carolina
– -$10K -2,868 Closed
Legal & General Group
52
Legal & General Group
United Kingdom
– -$8K -2,122 Closed
SO
53
STRS Ohio
Ohio
– -$7K -1,900 Closed
AB
54
Amalgamated Bank
New York
– -$5K -1,232 Closed
Royal Bank of Canada
55
Royal Bank of Canada
Ontario, Canada
– -$4K -1,147 Closed
AIP
56
Ameritas Investment Partners
Nebraska
– -$2K -641 Closed
PHK
57
Point72 Hong Kong
Hong Kong
– -$1K -231 Closed
1 2
3